How many investments has TransPacific Venture Partners made?

TransPacific Venture Partners has 12 tracked investments.

What stage does TransPacific Venture Partners invest at?

TransPacific Venture Partners invests at the Seed, Series A, Series B stages.

What is TransPacific Venture Partners's typical check size?

TransPacific Venture Partners typically writes checks of $500K – $3M.

What sectors does TransPacific Venture Partners focus on?

TransPacific Venture Partners focuses on Biotech, Digital Health, Healthtech, Medical Devices.

Where is TransPacific Venture Partners located?

TransPacific Venture Partners is headquartered in Taipei City, TW.

Who does TransPacific Venture Partners co-invest with?

TransPacific Venture Partners most often shares deals with Cota Capital, Geekdom, Rising Tide, among 6 tracked co-investors.

TransPacific Venture Partners

Venture capital

Taipei City · Seed–Series B · 2 people tracked

★ Follow + Add to CRM ⤳ Find an introduction

Find your way into TransPacific Venture Partners

131 people in our graph share verified history with the TransPacific Venture Partners team — schools, employers, funds. One of them is your warm intro.

Kristen Dumbeckunlockedknows Michelle Lin · together at Prudential Financial (overlapped)

knows the team · via Prudential Financial

×5knows the team · via De Anza College

×5knows the team · via California State University - East Bay

✨ Fox Verdict

Investment thesis

TPV focuses on early-stage medical technology ventures across Asia, proactively identifying unmet clinical needs and funding companies that build new healthcare products. Its partners draw on backgrounds in medicine, engineering, venture investing and startup founding. The firm brings a global perspective to local entrepreneurs while leveraging strategic relationships in Asia to offer an international blend of clinical, technical and strategic expertise. TPV helps portfolio companies reach value inflection points and aims to bring innovations to rapidly growing Asian markets to benefit patients worldwide. Typical initial checks range from $500K to $3 million in early-stage companies, with reserves kept for follow-on financings.

Invests inBiotech Digital Health Healthtech Medical Devices Asia-Pacific Israel Taipei Taiwan United States

Source: firm website, verified Aug 3, 2026.

Stage

Seed–Series B

Check

$500K – $3M

Taipei City, TW

Instruments

Equity

Founded

2012

Tracked investments

Team · 2 people

from the firm's website & public directories

Michelle Lin· Founder and General Partner· Taipeiin

Founder and General Partner of TransPacific Venture Partners with a PhD, she sits on the board of TSC Bio-venture Inc. and several biomed startups. She previously served as Secretary General of the Taiwan Bio-Industry Organization (2006-2010) and held senior government roles shaping Taiwan's biotech policy, including Director of the Biotech Office at the Executive Yuan.

Peter J. Fitzgerald· Partner· Stanford, California

An interventional cardiologist and Professor of Medicine at Stanford, holding an MD and PhD in Biomedical Engineering. He has participated in over 100 clinical trials, published extensively, co-founded more than a dozen medical device startups, and helped establish two healthcare-focused venture funds.

What they invest in

from 7 of 12 portfolio companies

Medical Devices ×6Digital Health ×4Healthtech ×4SaaS ×2AI & Machine Learning ×1Biotech ×1FemTech ×1Fintech ×1

HQs:Taiwan×2United States×2Austria×1

Investments · 12 tracked

founders shown can be your intro path

19Labs19labs.com in

19Labs builds GALE, a smart point-of-care platform that brings a full clinic experience to schools, rural communities, and pharmacies.

Digital HealthHealthtechMedical Devices

Ram Fish(Founder & CEO)inGerald Horel(Founder)in

Co-investorsTorrey Pines Investment

Apreventmedapreventmed.com in

APrevent is a medical device company developing solutions for voice and speech disorders, including the VOIS adjustable long-term vocal implant to treat glottic insufficiency and AiSpeak, a SaaS speech conversion platform for patients with dysarthria.

HealthtechMedical DevicesSaaSVienna, AT

Co-investorsTaiwania Capital

Ausense Biotech

Develops an adjustable balloon implant and surgical device to prevent aspiration pneumonia in stroke patients.

AXcelSci

Mobile medical technology company using smartphone sensors combined with optical test-strip technology to give users real-time readings of key biomarkers such as blood glucose and cholesterol.

Episonicaepisonica.com

FEMSelectfemselect.com in 𝕏

FemSelect develops EnPlace, an FDA-cleared, minimally invasive same-day treatment for Pelvic Organ Prolapse in women.

Digital HealthFemTechMedical Devices

Sasha Schrodein

Co-investorsRobin Hood Ventures Triventures New Age Ventures

iMed Solutions

Women's health company developing an automated whole-breast ultrasound scanning system for breast cancer screening and an MRI-guided high-intensity focused ultrasound device to treat uterine fibroids.

Ixensorixensor.com in

iXensor offers PixoTest Vision, an at-home testing device that measures multiple metabolic markers in three minutes and uses AI to analyze trends and generate personalized wellness and lifestyle plans.

AI & Machine LearningDigital HealthMedical Devices

Pop Medicalpop-medical.com

Puracathpuracath.comJun 2020

PuraCath Medical develops disinfection technology for catheter connections designed to reduce infection risk in healthcare settings.

BiotechHealthtechMedical DevicesSilicon Valley, US

Julia Rasooly(CEO)

Co-investorsCota Capital Geekdom Rising Tide

Somnicssomnics.com in

Somnics develops iNAP, a mask-free sleep apnea therapy that uses intraoral negative air pressure as an alternative to CPAP, oral appliances, and positional aids.

Digital HealthHardwareHealthtechMedical Devices

Yifteeyiftee.com in

Yiftee provides eGift Cards and its Community Card, a single card redeemable across a curated network of local merchants, to keep consumer spending within local business economies.

FintechImpact & Social GoodRetail TechSaaS

Co-investorsMohr Davidow Ventures

Portfolio news

latest coverage across their companies

FEMSelect Announces Close of Oversubscribed Series B Equity Financing to Drive Commercial Growth, Leadership Transformation, and Global Expansion - FEMSelect

FEMSelect · femselect.com · Feb 3, 2026

Frequently asked questions

How many investments has TransPacific Venture Partners made?: TransPacific Venture Partners has 12 tracked investments.
What stage does TransPacific Venture Partners invest at?: TransPacific Venture Partners invests at the Seed, Series A, Series B stages.
What is TransPacific Venture Partners's typical check size?: TransPacific Venture Partners typically writes checks of $500K – $3M.
What sectors does TransPacific Venture Partners focus on?: TransPacific Venture Partners focuses on Biotech, Digital Health, Healthtech, Medical Devices.
Where is TransPacific Venture Partners located?: TransPacific Venture Partners is headquartered in Taipei City, TW.
Who does TransPacific Venture Partners co-invest with?: TransPacific Venture Partners most often shares deals with Cota Capital, Geekdom, Rising Tide, among 6 tracked co-investors.

Similar investors

Amadeus Capital Partners

Amadeus Capital Partners is a technology investment firm that backs founders building complex, science-led and deep tech businesses, supporting them over the long term as they scale internationally.

$50K – $12.7M

Capricorn Venture Partners

Capricorn Partners is a Belgium-based, partner-owned independent management company for alternative investment funds, investing in innovative companies across digital, health and clean technologies with an ESG focus.

$270K – $10.8M

Eight Roads Ventures

Eight Roads Ventures is a venture capital firm that backs and partners with technology and healthcare companies.

$5M – $30M

Kleiner Perkins

Kleiner Perkins is a venture capital firm that backs founders across technology and life sciences, from early stage through growth.

$500K – $15M

Third Rock Ventures

Third Rock Ventures is a venture capital firm that discovers, launches, and builds life sciences and biotechnology companies developing novel medicines and therapies.

$100K – $5M